Functional validation using antibody blockade in patient‐derived organoid models recapitulated ITGA2's tumor‐promotive effects, though conserved oncogenic mechanisms between pediatric and adult cohorts warrant further exploration. This evidence concerns the gene ITGA2 and neoplasm.